Webinar: Pharmacy DIR Fees and the Medicare Part D Proposed Rule Wednesday, December 19, 2018 (11am - 12pm US/Eastern)

The registration period for this meeting has ended.

Hard to explain and impossible to predict, DIR fees remain the ultimate source of frustration for pharmacies across the board. Indeed, these retroactive rebates (i.e. price concessions) are bad for consumer wallets and pharmacies alike. So, what are DIR fees exactly and why do they exist? More importantly, how would the Administration’s recent Medicare Part D 2020 Proposed Rule impact DIR fees, and what can be done to further ease their burden on FMI member pharmacy businesses?

Join FMI for a webinar presentation featuring expert legal counsel from the law firm Quarles and Brady, who will address these questions and more. Attendees will walk away with a greater understanding of DIR fees, including what they need to know about the proposed rule, as well as tips for crafting the DIR fee contract language with pharmacy benefit managers (PBMs) in a favorable manner. This webinar is intended for FMI legal community, pharmacy leaders and government affairs gurus.